Literature DB >> 17321717

A meta-analysis of CBT for pathological worry among clients with GAD.

Roger Covin1, Allison J Ouimet, Pamela M Seeds, David J A Dozois.   

Abstract

Previous meta-analyses assessing the effectiveness of Cognitive Behavioural Therapy (CBT) for Generalized Anxiety Disorder (GAD) used general measures of anxiety to assess symptom severity and improvement (e.g., Hamilton Anxiety Ratings Scale or a composite measure of anxiety). While informative, these studies do not provide sufficient evidence as to whether CBT significantly reduces the cardinal symptom of GAD: pathological worry. The current meta-analysis employed stringent inclusion criteria to evaluate relevant outcome studies, including the use of the Penn State Worry Questionnaire as the main outcome variable. Results showed a large overall effect size (ES) that was moderated by age and modality of treatment. Specifically, the largest gains were found for younger adults and for individual treatment. Analyses also revealed overall maintenance of gains at 6- and 12-month follow-up. Clinical implications of different treatment packages are discussed, as well as potential explanations for the differential effectiveness of CBT.

Entities:  

Mesh:

Year:  2007        PMID: 17321717     DOI: 10.1016/j.janxdis.2007.01.002

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  38 in total

Review 1.  Generalised anxiety disorder.

Authors:  Christopher K Gale; Jane Millichamp
Journal:  BMJ Clin Evid       Date:  2011-10-27

Review 2.  Generalised anxiety disorder.

Authors:  Christopher K Gale; Jane Millichamp
Journal:  BMJ Clin Evid       Date:  2007-11-20

3.  Emotion Reactivity and Cerebrovascular Burden in Late-Life GAD: A Neuroimaging Study.

Authors:  Helmet Karim; Dana Larisa Tudorascu; Howard Aizenstein; Sarah Walker; Rachel Good; Carmen Andreescu
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-21       Impact factor: 4.105

4.  No End in Sight: Benzodiazepine Use in Older Adults in the United States.

Authors:  Donovan T Maust; Helen C Kales; Ilse R Wiechers; Frederic C Blow; Mark Olfson
Journal:  J Am Geriatr Soc       Date:  2016-11-23       Impact factor: 5.562

5.  Age differences in treatment response to a collaborative care intervention for anxiety disorders.

Authors:  Julie Loebach Wetherell; Andrew J Petkus; Steven R Thorp; Murray B Stein; Denise A Chavira; Laura Campbell-Sills; Michelle G Craske; Cathy Sherbourne; Alexander Bystritsky; Greer Sullivan; Peter Roy-Byrne
Journal:  Br J Psychiatry       Date:  2013-04-11       Impact factor: 9.319

6.  Information processing bias and pharmacotherapy outcome in older adults with generalized anxiety disorder.

Authors:  Amanda R W Steiner; Andrew J Petkus; Hoang Nguyen; Julie Loebach Wetherell
Journal:  J Anxiety Disord       Date:  2012-11-21

7.  Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder.

Authors:  Helen Christensen; Adam J Guastella; Andrew J Mackinnon; Kathleen M Griffiths; Claire Eagleson; Philip J Batterham; Kanupriya Kalia; Justin Kenardy; Kylie Bennett; Ian B Hickie
Journal:  Trials       Date:  2010-04-30       Impact factor: 2.279

8.  The longitudinal relationship between worry and disordered eating: Is worry a precursor or consequence of disordered eating?

Authors:  Margarita Sala; Cheri A Levinson
Journal:  Eat Behav       Date:  2016-07-15

9.  Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.

Authors:  Carmen Andreescu; Lei K Sheu; Dana Tudorascu; James J Gross; Sarah Walker; Layla Banihashemi; Howard Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2014-05-17       Impact factor: 4.105

10.  A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions.

Authors:  Chloe Foster; Helen Startup; Laura Potts; Daniel Freeman
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.